CareDx prelim Q4 rev $81.9-82.2M (+4% YoY); FY22 rev ~$321M (+8%); $50M buyback authorized

CareDx, Inc.

2022-FY EPS reported -$1.44 revenue$321,793,000

Preliminary Q4 2022 revenue $81.9-82.2M vs $79.2M in Q4 2021; testing services rev $64.9-65.2M (down from $68.6M).
Patient testing volume ~47,700 (+14% YoY), including ~2,300 AlloSure Lung tests.
Authorized $50M share buyback; cash & equivalents ~$292M with no debt.
Patient and digital solutions rev $28.8M in FY22 vs $10.3M in FY21, a 180% increase.
CEO targets adjusted EBITDA profitability in H1 2023; full guidance on Feb 2023 call.

item 2.02 item 9.01 item 7.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CareDx, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $81.9 million to $82.2 million.

Period: the fourth quarter ended December 31, 2022
Revenue: $81.9 million to $82.2 million
Result: preliminary results

Exact text from the filing

Preliminary revenue for the three months ended December 31, 2022, is expected to be between $81.9 million and $82.2 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CareDx, Inc. reported the full year ended December 31, 2022 results: revenue $321.3 million to $321.6 million.

Period: the full year ended December 31, 2022
Revenue: $321.3 million to $321.6 million
Result: preliminary results

Exact text from the filing

Preliminary revenue for the full year ended December 31, 2022, is expected to be between $321.3 million and $321.6 million

View on SEC.gov

Browse all earnings releases →

CareDx, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-004117

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.